By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Coming Soon
A prescription drug called CELLCEPT® (mycophenolate mofetil) is used to treat transplant recipients who have had rejection after receiving a kidney, heart, or liver. When the new organ is rejected, the body’s immune system fights it because it thinks it poses a “foreign” threat.
Mycophenolic acid is an immunosuppressant drug used to treat autoimmune diseases like Crohn’s disease and lupus as well as to avoid rejection after organ donation. It is used specifically after liver, heart, and kidney transplantation. It may be administered orally or intravenously via injection.
Nausea, vomiting, and diarrhoea are the most frequent adverse reactions. If mycophenolate is given with food or in the evening, these can be decreased.
The Global Mycophenolate Market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.
RECENT DEVELOPMENT
When an adult or child 3 months of age or older receives a kidney, heart, or liver transplant, mycophenolate (CellCept), together with other drugs, helps to prevent transplant organ rejection (the immune system of the recipient’s body attacking the donated organ).
When used with other drugs, mycophenolate (Myfortic) helps adults and children 5 years of age and older avoid their bodies rejecting kidney transplants.
Immunosuppressive agents, which include mycophenolate, are a group of drugs. The immune system of the body is weakened in order for the transplanted organ to not be attacked and rejected by the body.
Differently from the drug in the solution, tablet, and capsule, the medication in the delayed-release tablet (Myfortic) is absorbed by the body (CellCept). These goods are incompatible with one another. Make that they receive the appropriate medication each time their prescription is filled.
Talk to the doctor and chemist as soon as possible if they believe they were given the incorrect drug. Avoid crushing, chewing, or splitting the tablets, delayed-release tablets, or capsules; instead, swallow them whole. Keep the capsules closed.
Avoid contact with their skin, eyes, and breathing in the powder if a capsule is unintentionally opened. If any contact occurs, thoroughly clean the afflicted area with soap and water; rinse eyes as well.
Crohn’s disease is also treated with mycophenolate (a condition in which the body attacks the lining of the digestive tract, causing pain, diarrhea, weight loss, and fever). Other prescriptions for this drug are possible;
